Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan

Osteosarcoma (OS) is a common malignant bone tumour mainly occurs in children and young adults between the ages of 10 to 30 years. Although the advance of technology and improvement in chemotherapy treatment for OS has significantly improved the survival rate in recent years, its poor prognosis and...

Full description

Bibliographic Details
Main Author:	Roslan, Zulaika
Format:	Thesis
Language:	English
Published:	2016
Subjects:	Organic substances
Online Access:	http://ir.uitm.edu.my/id/eprint/18764/ http://ir.uitm.edu.my/id/eprint/18764/1/TM_ZULAIKA%20ROSLAN%20MD%2016_5.pdf

id	uitm-18764
recordtype	eprints
spelling	uitm-187642018-01-22T03:18:50Z http://ir.uitm.edu.my/id/eprint/18764/ Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan Roslan, Zulaika Organic substances Osteosarcoma (OS) is a common malignant bone tumour mainly occurs in children and young adults between the ages of 10 to 30 years. Although the advance of technology and improvement in chemotherapy treatment for OS has significantly improved the survival rate in recent years, its poor prognosis and unknown etiology continues to remain the major challenge in managing the disease progression. Therefore, the objectives of this study are to establish the serum protein profile of OS patients, to investigate the differential protein expression in pre and postchemotherapy and to identify the potential protein biomarkers relevant in OS cell migration. Serum and bone tissues biopsies were collected from healthy volunteers, pre- and post-chemotherapy OS patients. In this study, OS serum protein profile was established using a 4-plex iTRAQ analysis. Approximately 217 proteins with 104,214 spectra were acquired which includes low abundance proteins involved in biological processes and other protein classes. In addition, VCAM-1 was significantly altered (p<0.05) and shown to be highly expressed in post-chemotherapy OS serum. VCAM- 1 and ICAM-3 expression was then verified using western blot and immunohistochemistry staining to observe their roles in OS cell migrations. To date, this is the first differential protein expression study to use OS patients' serum at different stages for the protein profiling. The comprehensive data on the differentially expressed protein was successfully generated and the comparative study has revealed a significant amount of protein expressed has been significantly altered. This data could provide a new insight on the fundamental OS biological processes and further use as a potential biomarker for better OS prognosis. 2016 Thesis NonPeerReviewed text en http://ir.uitm.edu.my/id/eprint/18764/1/TM_ZULAIKA%20ROSLAN%20MD%2016_5.pdf Roslan, Zulaika (2016) Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan. Masters thesis, Universiti Teknologi MARA.
repository_type	Digital Repository
institution_category	Local University
institution	Universiti Teknologi MARA
building	UiTM Institutional Repository
collection	Online Access
language	English
topic	Organic substances
spellingShingle	Organic substances Roslan, Zulaika Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan
description	Osteosarcoma (OS) is a common malignant bone tumour mainly occurs in children and young adults between the ages of 10 to 30 years. Although the advance of technology and improvement in chemotherapy treatment for OS has significantly improved the survival rate in recent years, its poor prognosis and unknown etiology continues to remain the major challenge in managing the disease progression. Therefore, the objectives of this study are to establish the serum protein profile of OS patients, to investigate the differential protein expression in pre and postchemotherapy and to identify the potential protein biomarkers relevant in OS cell migration. Serum and bone tissues biopsies were collected from healthy volunteers, pre- and post-chemotherapy OS patients. In this study, OS serum protein profile was established using a 4-plex iTRAQ analysis. Approximately 217 proteins with 104,214 spectra were acquired which includes low abundance proteins involved in biological processes and other protein classes. In addition, VCAM-1 was significantly altered (p<0.05) and shown to be highly expressed in post-chemotherapy OS serum. VCAM- 1 and ICAM-3 expression was then verified using western blot and immunohistochemistry staining to observe their roles in OS cell migrations. To date, this is the first differential protein expression study to use OS patients' serum at different stages for the protein profiling. The comprehensive data on the differentially expressed protein was successfully generated and the comparative study has revealed a significant amount of protein expressed has been significantly altered. This data could provide a new insight on the fundamental OS biological processes and further use as a potential biomarker for better OS prognosis.
format	Thesis
author	Roslan, Zulaika
author_facet	Roslan, Zulaika
author_sort	Roslan, Zulaika
title	Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan
title_short	Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan
title_full	Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan
title_fullStr	Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan
title_full_unstemmed	Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan
title_sort	proteomic profiling for potential biomarkers of osteosarcoma patients / zulaika roslan
publishDate	2016
url	http://ir.uitm.edu.my/id/eprint/18764/ http://ir.uitm.edu.my/id/eprint/18764/1/TM_ZULAIKA%20ROSLAN%20MD%2016_5.pdf
first_indexed	2023-09-18T23:01:10Z
last_indexed	2023-09-18T23:01:10Z
_version_	1777418182824296448

Proteomic profiling for potential biomarkers of osteosarcoma patients / Zulaika Roslan

Similar Items